146 related articles for article (PubMed ID: 37448768)
1. Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia.
Georgakopoulou VE; Gkoufa A; Bougea A; Basoulis D; Tsakanikas A; Makrodimitri S; Karamanakos G; Spandidos DA; Angelopoulou E; Sipsas NV
Med Int (Lond); 2023; 3(4):34. PubMed ID: 37448768
[TBL] [Abstract][Full Text] [Related]
2. Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia.
Georgakopoulou VE; Gkoufa A; Tsakanikas A; Makrodimitri S; Karamanakos G; Basoulis D; Voutsinas PM; Eliadi I; Bougea A; Spandidos DA; Angelopoulou E; Steiropoulos P; Sipsas NV
Exp Ther Med; 2023 Aug; 26(2):395. PubMed ID: 37456163
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia.
Georgakopoulou VE; Gkoufa A; Makrodimitri S; Tsakanikas A; Basoulis D; Voutsinas PM; Karamanakos G; Eliadi I; Samara S; Triantafyllou M; Eleftheriadou I; Kampouropoulou O; Papageorgiou CV; Anastasopoulou A; Papalexis P; Trakas I; Trakas N; Spandidos DA; Steiropoulos P; Sipsas NV
Exp Ther Med; 2024 Jan; 27(1):22. PubMed ID: 38125348
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
5. Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant predominance.
Mathioudakis N; Zachiotis M; Papadakos S; Triantafyllou M; Karapanou A; Samara S; Karamanakos G; Spandidos DA; Papalexis P; Damaskos C; Tarantinos K; Fotakopoulos G; Sklapani P; Trakas N; Sipsas NV; Georgakopoulou VE
Exp Ther Med; 2022 Nov; 24(5):675. PubMed ID: 36177343
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.
Bohnert AS; Kumbier K; Rowneki M; Gupta A; Bajema K; Hynes DM; Viglianti E; O'Hare AM; Osborne T; Boyko EJ; Young-Xu Y; Iwashyna TJ; Maciejewski M; Schildhouse R; Dimcheff D; Ioannou GN
BMJ; 2023 May; 381():e074521. PubMed ID: 37220941
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
11. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.
Georgakopoulou VE; Basoulis D; Voutsinas PM; Makrodimitri S; Samara S; Triantafyllou M; Eliadi I; Karamanakos G; Papageorgiou CV; Anastasopoulou A; Bitsani A; Kampouropoulou O; Eleftheriadou I; Gkoufa A; Spandidos DA; Papalexis P; Sipsas NV
Exp Ther Med; 2022 Dec; 24(6):724. PubMed ID: 36340609
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Variants Infection in Relationship to Imaging-based Pneumonia and Clinical Outcomes.
Lee JE; Hwang M; Kim YH; Chung MJ; Sim BH; Jeong WG; Jeong YJ
Radiology; 2023 Mar; 306(3):e221795. PubMed ID: 36165791
[TBL] [Abstract][Full Text] [Related]
15. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods.
Stupica D; Collinet-Adler S; Kejžar N; Poljak M; Štamol T
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769609
[TBL] [Abstract][Full Text] [Related]
17. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
[TBL] [Abstract][Full Text] [Related]
18. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
Stepanova M; Lam B; Younossi E; Felix S; Ziayee M; Price J; Pham H; de Avila L; Terra K; Austin P; Jeffers T; Escheik C; Golabi P; Cable R; Srishord M; Venkatesan C; Henry L; Gerber L; Younossi ZM
BMC Infect Dis; 2022 Aug; 22(1):702. PubMed ID: 35996076
[TBL] [Abstract][Full Text] [Related]
19. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
medRxiv; 2022 Feb; ():. PubMed ID: 35169811
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
